bourse

#Pharma #Bourse #Biotech How Much Should You Pay For Incyte? - SeekingAlpha http://t.co/NL7wp9OL76 jallatte (@jallatte) June 26, 2013 Incyte ( INCY) is a mid-cap biopharmaceutical company that develops kinase inhibitors with broad applications for cancers...

#Pharma #Bourse Sanofi, Novartis and GSK in race to buy Elder Pharma's domestic formulations business - http://t.co/Mah86WwKbQ cc @Mtu31 jallatte (@jallatte) June 26, 2013 MUMBAI: Multinational pharmaceutical majors such as Sanofi, Novartis and GSK are...

#Pharma #Bourse Glaxo's diabetes drug fails to beat Takeda's Actos in head-to-head study - FierceBiotech http://t.co/04YbQqHccm jallatte (@jallatte) June 26, 2013 CHICAGO--GlaxoSmithKline's ($GSK) experimental diabetes drug proved to be at least as good...

#Pharma #Bourse Bayer enters into collaboration with Seattle Genetics for development of anticancer drugs http://t.co/3G8SxB7DVe jallatte (@jallatte) June 26, 2013 Bayer says that its Bayer HealthCare subgroup has entered into a new antibody-drug conjugate...

#Pharma #Bourse Roche, Astra to Share Drug Research Data - WSJ http://t.co/RILYiHLjxs jallatte (@jallatte) June 26, 2013 In another example of big drug companies pooling resources to try to improve R&D, Roche and AstraZeneca will share data on early-stage...

#Pharma #Bourse Transgene : reprise d'actifs en Inde http://t.co/ttzd6dnqLq cc @ghabault jallatte (@jallatte) June 25, 2013 (Boursier.com) -- Transgene annonce que Platine Pharma Services SAS, l'une de ses participations spécialisée dans les prestations...

#Bourse Pour le cours du sanglier rôti suivre @ALarigaudrieBFM sur @bfmbusiness jallatte (@jallatte) June 25, 2013

#Pharma #Bourse Newron place de nouvelles actions dans le cadre d'une augmentation de capital http://t.co/ZczzhB6SzL cc @ghabault jallatte (@jallatte) June 24, 2013 Newron place de nouvelles actions dans le cadre d'une augmentation de capital

La #biotech Cardio3 BioSciences s'introduit en #Bourse - Capital.fr http://t.co/xVk2rIiVkV cc @ghabault jallatte (@jallatte) June 24, 2013 La société de biotechnologie Cardio3 BioSciences, un leader dans la découverte et le développement de thérapies...

#Pharma #Bourse AstraZeneca seeks to share drug development cost - FTcom http://t.co/DL7XMjzsZp cc @ghabault jallatte (@jallatte) June 24, 2013 AstraZeneca is considering a big strategic alliance with another pharmaceutical company to share the costs...